ATE476501T1 - Verfahren zur reinigung von factor vii - Google Patents

Verfahren zur reinigung von factor vii

Info

Publication number
ATE476501T1
ATE476501T1 AT06700982T AT06700982T ATE476501T1 AT E476501 T1 ATE476501 T1 AT E476501T1 AT 06700982 T AT06700982 T AT 06700982T AT 06700982 T AT06700982 T AT 06700982T AT E476501 T1 ATE476501 T1 AT E476501T1
Authority
AT
Austria
Prior art keywords
factor vii
procedure
purifying factor
purifying
rfvii
Prior art date
Application number
AT06700982T
Other languages
English (en)
Inventor
Rikkle Bolding Jensen
Frank Bech Nygaard
Original Assignee
Bayer Healthcare Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Llc filed Critical Bayer Healthcare Llc
Application granted granted Critical
Publication of ATE476501T1 publication Critical patent/ATE476501T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Processing Of Solid Wastes (AREA)
AT06700982T 2005-01-14 2006-01-13 Verfahren zur reinigung von factor vii ATE476501T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64412605P 2005-01-14 2005-01-14
PCT/DK2006/000024 WO2006074664A1 (en) 2005-01-14 2006-01-13 Method for purification of factor vii

Publications (1)

Publication Number Publication Date
ATE476501T1 true ATE476501T1 (de) 2010-08-15

Family

ID=36010990

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06700982T ATE476501T1 (de) 2005-01-14 2006-01-13 Verfahren zur reinigung von factor vii

Country Status (10)

Country Link
US (1) US20090047723A1 (de)
EP (1) EP1841863B1 (de)
AT (1) ATE476501T1 (de)
CY (1) CY1110867T1 (de)
DE (1) DE602006015907D1 (de)
DK (1) DK1841863T3 (de)
ES (1) ES2349112T3 (de)
PL (1) PL1841863T3 (de)
PT (1) PT1841863E (de)
WO (1) WO2006074664A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0608170A2 (pt) * 2005-04-28 2010-11-09 Novo Nordisk Healthcare Ag recipiente fechado contendo uma composição de um polipeptìdeo do fator vii ativado, processo para a preparação de um recipiente fechado contendo um polipeptìdeo do fator vii ativado, kit, e, método para a preparação de uma composição farmacêutica
FR2901796A1 (fr) * 2006-05-31 2007-12-07 Lab Francais Du Fractionnement Procede d'extraction d'une ou de plusieurs proteines presentes dans du lait
HUE040636T2 (hu) 2009-06-16 2019-03-28 Genzyme Corp Javított eljárások rekombináns AAV-vektorok tisztítására
WO2011088225A1 (en) * 2010-01-15 2011-07-21 Bio-Rad Laboratories, Inc. Surface neutralization of apatite
US8895707B2 (en) 2010-08-18 2014-11-25 Bio-Rad Laboratories, Inc. Elution of proteins from hydroxyapatite resins without resin deterioration
US8795658B2 (en) 2010-09-17 2014-08-05 Baxter International Inc. Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral pH
AU2011343813B2 (en) 2010-12-15 2015-05-21 Takeda Pharmaceutical Company Limited Eluate collection using conductivity gradient
EP2670704B1 (de) 2011-02-02 2018-12-12 Bio-Rad Laboratories, Inc. Apatitoberflächenneutralisierung mit alkalischen lösungen
US9815695B2 (en) 2012-05-30 2017-11-14 Bio-Rad Laboratories, Inc. In situ restoration of apatite-based chromatography resins
JP6297029B2 (ja) * 2012-05-31 2018-03-20 エイジェンシー・フォー・サイエンス，テクノロジー・アンド・リサーチ 多様な官能基を有する粒子による免疫グロブリンｇ調製物のクロマトグラフィー精製
US9175279B1 (en) 2013-03-15 2015-11-03 Csl Limited Method of purifying factor VII and/or factor VIIa
US9802822B2 (en) 2014-06-23 2017-10-31 Bio-Rad Laboratories, Inc. Apatite pretreatment
WO2015200299A2 (en) 2014-06-23 2015-12-30 Bio-Rad Laboratories, Inc. Apatite in-situ restoration
CA3036527A1 (en) 2016-09-13 2018-03-22 Bayer Healthcare Llc Factor viia glycoforms

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4473553A (en) * 1983-12-02 1984-09-25 Miles Laboratories, Inc. Process for producing a lipoprotein-poor concentrate of coagulation factors VII and VIIa
US4470969A (en) * 1983-12-02 1984-09-11 Miles Laboratories, Inc. Process for producing a concentrate of coagulation factors VII and VIIa
US4637932A (en) * 1984-10-15 1987-01-20 Miles Laboratories, Inc. Process for producing a concentrate enriched in coagulation factors VII and VIIa
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins
DK38293D0 (da) * 1993-03-31 1993-03-31 Novo Nordisk As Fremstilling af proteiner
DE4406515C1 (de) * 1994-02-28 1995-10-19 Immuno Ag Verfahren zur Isolierung und Reinigung Vitamin K-abhängiger Proteine
AT408613B (de) * 1998-06-17 2002-01-25 Immuno Ag Pharmazeutisches faktor vii-präparat
US6451987B1 (en) * 1999-03-15 2002-09-17 Novo Nordisk A/S Ion exchange chromatography of proteins and peptides
DE19937218A1 (de) * 1999-08-06 2001-02-08 Aventis Behring Gmbh Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Affinitätschromatographie
US7897734B2 (en) * 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
US20070037966A1 (en) * 2004-05-04 2007-02-15 Novo Nordisk A/S Hydrophobic interaction chromatography purification of factor VII polypeptides

Also Published As

Publication number Publication date
PT1841863E (pt) 2010-10-25
US20090047723A1 (en) 2009-02-19
EP1841863A1 (de) 2007-10-10
DE602006015907D1 (de) 2010-09-16
ES2349112T3 (es) 2010-12-28
WO2006074664A1 (en) 2006-07-20
PL1841863T3 (pl) 2011-05-31
CY1110867T1 (el) 2015-06-10
EP1841863B1 (de) 2010-08-04
DK1841863T3 (da) 2010-11-29

Similar Documents

Publication Publication Date Title
CY1110867T1 (el) Μεθοδος για τον καθαρισμο του παραγοντα vii
DE502006007617D1 (de) Flüssigkeitsabsorption durch metallorganische Gerüstmaterialien
TW200738270A (en) Method of treating depression using a TNFα antibody
NO20062087L (no) Bispesifikt antistoff som substituerer for funksjonelle proteiner
ATE532518T1 (de) Dipeptidyl-peptidase-hemmer zur behandlung von diabetes
DE502006000218D1 (de) Verfahren zur Herstellung von SiOC-verknüpften, linearen Polydialkylsiloxan-Polyoxyalkylen-Blockcopolymeren
DE602007006610D1 (de) Isolationsdurchdringendes und SMD fähiges Kontaktelement , sowie Verfahren zu dessen Nutzung.
EP1899865A4 (de) Verfahren, system, vorrichtung und computerprogramm zur aktivierung des vorab-downloads von medienobjekten
ATE475419T1 (de) Verfahren zur zubereitung von lansoprazol
EP1904227A4 (de) Scr-katalysator zur entfernung von stickoxiden
WO2005105276A3 (en) Device with a membrane on a carrier, as well as a method for manufacturing such a membrane
EP1846185A4 (de) Verbundwerkstoffschiene, säule und andere träger, einschliesslich für maschinen
NO20063304L (no) Fremgangsmate til a rense FSH
DK1519944T3 (da) Fremgangsmåder til fremstilling af fibrinogen
EP1599301A4 (de) Verbundwerkstoffschiene, -säule und andere träger, einschliesslich für maschinen
WO2007068910A3 (en) Oligomerisation
DE602006008892D1 (de) Kompaktes system zur verpackung von injizierbaren gungen
WO2005076743A3 (en) Disaccharide molecules and derivatives thereof and methods of using same
DE602006008581D1 (de) Verfahren zur bestimmung von montagebedingungen, vorrichtung zur bestimmung von montagebedingungen und montagevorrichtung
WO2006114105A3 (en) Use of modified factor vii for treating bleeding
ATE555019T1 (de) Verfahren zur erzeugung flüssiger zubereitungen mit festkörpergehalt
WO2008059041A3 (en) Complementation of factor xi deficiency by factor v mutants
DK1817342T3 (da) Fremgangsmåde til affinitetsrensning
ATE394369T1 (de) Verfahren zur aufreinigung von mesotrion
DE502005003816D1 (de) System zum Erzeugen von Lenkwinkeln

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1841863

Country of ref document: EP